Clinical Trials in CPR

Out-of-hospital cardiac arrest is a common and lethal problem, with an estimated 330,000 deaths each year in North America alone. Even in those cases where help arrives in a timely fashion, outcomes remain dismal with estimates of survival to hospital discharge ranging from 3.0% to 16.3%.  Compounding the situation is the difficulty associated with conducting […]

Read More…

Ambulatory BP Monitoring Cost-Effective

Affecting a billion people, hypertension is the cardiovascular risk factor associated with the highest mortality worldwide. There are well-documented problems in the detection of hypertension, as it varies throughout the day and in response to various stimuli. Out-of-office options have been developed that monitor blood pressure either at home or whilst ambulatory, and have been […]

Read More…

Cardiac biomarkers and prognosis in COPD

Cardiovascular disease is common in patients with COPD with the two conditions often being linked by the common aetiology of smoking.  Moreover, dysfunction in one organ system can transmit to the other with severe hypoxemia, pulmonary hypertension, and systemic inflammation all potentially impacting on cardiac function.  However, the interplay between lung and cardiac disease is […]

Read More…

Operator Experience Influences Carotid Stenting Outcomes

The US Food and Drug Administration (FDA) approved the first carotid stenting system in 2004, and since then the use of the procedure has steadily increased in America.  However, carotid stenting is a technically demanding procedure, and several studies have noted a significant learning curve for operators performing the procedure.  This study investigated the experience […]

Read More…

High Residual Platelet Reactivity Predicts Future Cardiovascular Events

With the increased use of platelet function testing, high residual platelet reactivity (HRPR) has been found to associate with a high risk of ischaemic events following percutaenous coronary intervention (PCI).  However, few data exist for patients with acute coronary syndromes (ACS).  To this end, the Responsiveness to Clopidogrel and Stent Thrombosis 2-ACS (RECLOSE 2-ACS) study […]

Read More…